EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
46 hedge funds and large institutions have $58.8M invested in ESSA Pharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.09% less ownership
Funds ownership: 79.11% → 74.03% (-5.1%)
72% less capital invested
Capital invested by funds: $213M → $58.8M (-$154M)
Holders
46
Holding in Top 10
1
Calls
$179K
Puts
$55K
Top Buyers
| 1 | +$7.7M | |
| 2 | +$7.56M | |
| 3 | +$3.96M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$2.56M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.45M |
Top Sellers
| 1 | -$47.8M | |
| 2 | -$16.6M | |
| 3 | -$8.93M | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$4.88M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$4.1M |